Struc­ture in part­ner­ing talks for GLP-1 pill as mid-stage read­out nears

6 days ago
R&D

Ex­clu­sive: Ger­man CD­MO BioSpring em­barks on €100M+ nu­cle­ic acid fac­to­ry

6 days ago
Manufacturing

Sage talked to 43 'coun­ter­par­ties' be­fore ink­ing Su­per­nus deal

6 days ago
Deals

4DMT lays off staff, reshuf­fles team as it dou­bles down on Phase 3 plans

6 days ago
People
R&D

Now pri­vate, blue­bird bio con­tin­ues lead­er­ship re­vamp; Roche R&D ex­ec an­nounces re­tire­ment

6 days ago
Peer Review

Dizal’s lung can­cer pill ap­proval sets up com­pe­ti­tion with J&J

6 days ago
Pharma
FDA+

FDA re­view­ers ad­vised broad la­bel for Mod­er­na’s next-gen Covid vac­cine. Prasad over­ruled them

Last week
Pharma
FDA+

Bris­tol My­er­s' Chi­na part­ner touts Phase 3 suc­cess for EGFRx­HER3 bis­pe­cif­ic ADC

Last week
R&D
China

Ab­b­Vie los­es bid to block Ten­nessee's 340B con­tract phar­ma­cy law

Last week
Pharma
Law

CDC ex­pands RSV vac­cine rec­om­men­da­tions, sid­ing with pre­vi­ous pan­el of agency ad­vi­sors

Last week
Pharma
FDA+

Af­ter de­lay, Re­gen­eron wins US ap­proval of bis­pe­cif­ic in mul­ti­ple myelo­ma

Last week
Pharma
FDA+

Vyne stops en­rolling ear­ly-stage pso­ri­a­sis study fol­low­ing clin­i­cal hold lift, ear­ly da­ta

Last week
R&D

Ab­b­Vie cans oral ul­cer­a­tive col­i­tis drug from Lan­dos buy­out

Last week
R&D
Pharma

Chi­na’s rise splits US biotech in­vestors: Cash in, or counter? 

Last week
China
In Focus

Organon stops work on drug once viewed as ‘game-chang­ing’; Next­Point culls an as­set

Last week
News Briefing

So­ri­ot mulls mov­ing As­traZeneca stock list­ing to the US — re­port

Last week
Pharma

Sh­iono­gi, BioVer­sys team up on an­tibi­otics for lung dis­ease in deal worth up to $614M

Last week
Deals
R&D

Fed­er­al judge or­ders block on parts of HHS re­or­ga­ni­za­tion plan af­ter states sue

Last week
Pharma
Law

PBM re­forms fail to make the cut as Sen­ate pass­es Trump’s mega­bill

Last week
R&D
Pharma

Ex­clu­sive: VC firm lines up $200M fund to cham­pi­on Japan­ese in­no­va­tion

Last week
Financing
Startups

The biggest health tech sto­ries of 2025 — so far

Last week
Health Tech

Broad In­sti­tute con­ducts lay­offs as it preps for cuts in fed­er­al fund­ing; Dyne’s fi­nanc­ing

Last week
News Briefing

Ad­vo­cates urge J&J to ‘put every­thing on the ta­ble’ for gene ther­a­py de­spite failed tri­al

Last week
R&D
Cell/Gene Tx

Kevin Tang's Con­cen­tra snags an­oth­er buy­out, this time for IGM Bio­sciences

Last week
Deals
First page Previous page 123456 Next page Last page
A service from the Financial Times